The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
05/13/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
RFA-HD-09-027
Opportunity Category:
Discretionary
Posted Date:
May 13, 2009
Creation Date:
May 13, 2009
Original Closing Date for Applications:
Nov 10, 2009
Current Closing Date for Applications:
Nov 10, 2009
Archive Date:
Dec 11, 2009
Funding Instrument Type:
Cooperative Agreement
Category of Funding Activity:
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
3
Estimated Total Program Funding:
$3,000,000
Award Ceiling:
$1,000,000
Award Floor:
CFDA Number(s):
93.837
--
Heart and Vascular Diseases Research
93.846
--
Arthritis, Musculoskeletal and Skin Diseases Research
93.853
--
Extramural Research Programs in the Neurosciences and Neurological Disorders
93.865
--
Child Health and Human Development Extramural Research
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs).
Agency Name
National Institutes of Health
Description
Purpose. This funding opportunity announcement (FOA) solicits new (type 1) and competitive renewal (type 2) applications for the support of Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (MDCRCs). Successful applicants will join a network of existing Centers to foster the translation of new scientific findings and technological developments into novel treatments for the muscular dystrophies. Each Center may contain a mixture of basic, translational, or clinical research, as long as efforts are directed toward the steps required for therapeutic development, including therapeutic target identification, characterization, and validation, development of diagnostics and biomarkers to characterize or stratify patient populations, in vitro assay development, animal model development and characterization, candidate therapeutic efficacy screening, preclinical therapeutic optimization and FDA-required activities leading to an investigational new drug (IND) application, clinical infrastructure and studies in support of a clinical trial, patient-oriented natural history studies, and early stage clinical trials for one or more types of muscular dystrophy. Applicants should propose multi-disciplinary and collaborative studies that address one or more gaps in the therapeutic development pipeline for muscular dystrophy. Research problems should require substantial collaborative efforts to solve, and thus are best carried out in a center setting.
Mechanism of Support. This FOA will utilize the U54 Specialized Centers Cooperative Agreement grant mechanism.
